1. Home
  2. XNDU vs TLX Comparison

XNDU vs TLX Comparison

Compare XNDU & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares

XNDU

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares

N/A

Current Price

$10.28

Market Cap

3.2B

Sector

N/A

ML Signal

N/A

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$10.22

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XNDU
TLX
Founded
2016
2015
Country
Canada
Australia
Employees
264
1184
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XNDU
TLX
Price
$10.28
$10.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$44.00
$21.13
AVG Volume (30 Days)
1.5M
146.1K
Earning Date
N/A
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$150.33
Revenue Growth
N/A
N/A
52 Week Low
$6.97
$6.28
52 Week High
$42.44
$14.27

Technical Indicators

Market Signals
Indicator
XNDU
TLX
Relative Strength Index (RSI) 40.48 43.37
Support Level $9.50 $10.12
Resistance Level $14.54 $11.38
Average True Range (ATR) 0.59 0.26
MACD 0.10 -0.16
Stochastic Oscillator 30.65 3.74

Price Performance

Historical Comparison
XNDU
TLX

About XNDU Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares

Xanadu Quantum Technologies Ltd specializes in designing photonic devices and the platforms around them, including the experimentation and development of quantum computers available on the cloud with supporting software, along with quantum simulators and other related products and offerings. Its products include: Aurora, PennyLane, Catalyst, Lightning, Catalyst and PennyLane Codebook. The company operates in industries such as automotive, aerospace, energy, materials, and semiconductor sectors.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: